P
Peter D. Schellinger
Researcher at Ruhr University Bochum
Publications - 262
Citations - 18189
Peter D. Schellinger is an academic researcher from Ruhr University Bochum. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 64, co-authored 240 publications receiving 15911 citations. Previous affiliations of Peter D. Schellinger include University Hospitals of the Ruhr-University of Bochum & Heidelberg University.
Papers
More filters
Journal ArticleDOI
Safety and Feasibility of Collateral Blood Flow Augmentation After Intravenous Thrombolysis
Derek Emery,Peter D. Schellinger,Daniel Selchen,Andre G. Douen,Richard Chan,Ashfaq Shuaib,Kenneth Butcher +6 more
TL;DR: Partial aortic occlusion as an adjunct to thrombolysis in the treatment of acute stroke appears safe and studies aimed at determining the efficacy of this therapeutic approach are warranted.
Journal ArticleDOI
Combined Lysis of Thrombus with Ultrasound and Systemic Tissue Plasminogen Activator for Emergent Revascularization in Acute Ischemic Stroke (Clotbust-ER): Design and Methodology of a Multinational Phase 3 Trial:
Peter D. Schellinger,Andrei V. Alexandrov,Andrew D Barreto,Andrew M. Demchuk,Georgios Tsivgoulis,Georgios Tsivgoulis,Martin Köhrmann,John Alleman,Virginia J. Howard,George Howard,Anne W. Alexandrov,Gordon Brandt,Carlos A. Molina +12 more
TL;DR: Since intravenous recombinant tissue-plasminogen-activator remains the only medical therapy to reverse ischemic stroke applicable in the emergency department, this trial will determine if the additional use of transcranial ultrasound improves functional outcomes in patients with severe acute ischems.
Journal ArticleDOI
Fatal oral anticoagulant-related intracranial hemorrhage: a systematic review and meta-analysis.
Aristeidis H. Katsanos,Aristeidis H. Katsanos,Peter D. Schellinger,Martin Köhrmann,Angeliki Filippatou,M. E. Gurol,Valeria Caso,M Paciaroni,Fabienne Perren,Andrei V. Alexandrov,Georgios Tsivgoulis,Georgios Tsivgoulis +11 more
TL;DR: A systematic review and meta‐analysis is performed to evaluate the risk of fatal NOAC‐related ICH compared with VKA‐ related ICH and non‐vitamin K oral anticoagulant NOACs reduce the risk.
Journal ArticleDOI
Therapeutic time window of thrombolytic therapy following stroke.
TL;DR: An overview of a diagnostic approach to acute stroke management that allows the clinician to individualize patient management based on pathophysiologic reasoning and not rigid time windows established by randomized controlled trials is presented.
Book ChapterDOI
Chapter 57 Thrombolytic therapy for acute stroke
TL;DR: Neuroradiological intervention with intra-arterial or intravenous thrombolysis to date is the only life-saving therapy that has demonstrated benefit with regard to mortality and outcome, albeit not in a randomized trial.